Compare · BIMI vs COR
BIMI vs COR
Side-by-side comparison of BIMI International Medical Inc. (BIMI) and Cencora Inc. (COR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BIMI and COR operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- COR carries a market cap of $66.90B.
- COR has hit the wire 22 times in the past 4 weeks while BIMI has been quiet.
- COR has more recent analyst coverage (25 ratings vs 0 for BIMI).
- Company
- BIMI International Medical Inc.
- Cencora Inc.
- Price
- -
- -
- Market cap
- -
- $66.90B
- 1M return
- -
- +3.07%
- 1Y return
- -
- -3.08%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 0
- 22
- Recent ratings
- 0
- 25
BIMI International Medical Inc.
BOQI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. It offers prescription and over-the-counter drugs, nutritional supplements, health foods, and sundry products, as well as traditional Chinese medicines, personal and family care products, and miscellaneous items under the Lijiantang Pharmacy brand name. The company also provides IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as NF Energy Saving Corporation and changed its name to BOQI International Medical Inc. in December 2019. BOQI International Medical Inc. was incorporated in 2000 and is based in Dalian, the People's Republic of China.
Cencora Inc.
CoreSite Realty Corporation (NYSE:COR) delivers secure, reliable, high-performance data center, cloud access and interconnection solutions to a growing customer ecosystem across eight key North American markets. More than 1,375 of the world's leading enterprises, network operators, cloud providers, and supporting service providers choose CoreSite to connect, protect and optimize their performance-sensitive data, applications and computing workloads. Our scalable, flexible solutions and 460+ dedicated employees consistently deliver unmatched data center options  all of which leads to a best-in-class customer experience and lasting relationships.
Latest BIMI
- BIMI International Medical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
- Director Oudom Fnu was granted 1,123,500 shares, increasing direct ownership by 285% to 1,518,243 units (SEC Form 4)
- BIMI International Medical Inc. filed SEC Form 8-K: Leadership Update
- 12 Health Care Stocks Moving In Monday's After-Market Session
- BIMI International Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Latest COR
- President & CEO Mauch Robert P. was granted 18,292 restricted stock units (SEC Form 4)
- Executive Vice President Campbell Elizabeth S was granted 4,402 restricted stock units (SEC Form 4)
- Chief Financial Officer Boratto Eva C was granted 5,488 restricted stock units (SEC Form 4)
- SVP & Chief Accounting Officer Krikorian Lazarus was granted 3,216 restricted stock units (SEC Form 4)
- EVP, Chief Data & Info Officer Verma Pawan was granted 4,231 restricted stock units (SEC Form 4)
- President & CEO Mauch Robert P. converted options into 40,271 shares and covered exercise/tax liability with 17,405 shares, increasing direct ownership by 34% to 90,652 units (SEC Form 4) (tax liability)
- SVP & Chief Accounting Officer Krikorian Lazarus converted options into 3,386 shares and covered exercise/tax liability with 1,457 shares, increasing direct ownership by 13% to 16,948 units (SEC Form 4) (withholding tax)
- Executive Vice President Campbell Elizabeth S converted options into 17,190 shares and covered exercise/tax liability with 7,947 shares, increasing direct ownership by 45% to 29,682 units (SEC Form 4) (for withholding tax)
- EVP, Chief Data & Info Officer Verma Pawan converted options into 1,321 shares and covered exercise/tax liability with 676 shares, increasing direct ownership by 7% to 10,077 units (SEC Form 4) to satisfy tax liability
- President & CEO Mauch Robert P. converted options into 4,066 shares and covered exercise/tax liability with 1,673 shares, increasing direct ownership by 4% to 67,786 units (SEC Form 4) (for withholding tax)